Interesting correlation on how the move business and Pharma share similar business plans when it comes to producing a blockbuster drug. R and D, yup, got high costs with both, unpredictable, yup, nobody knows until the release, budgets and flops, well it could be a toss up over which industry can...
Pfizer is wasting no time to get the calculations running and numbers rolling. To stay in the market, they are attempting to find out as much as they can about potential side effects and other perhaps adverse affects of their drugs. Better than they find up them front, as it will make for better...
Posted to
The Medical Quack .... by Barbara Duck
on 07-15-2008
Filed under: Medically Related, Technology, Pharma/FDA News, personalized medicine, DNA, drugs, Biotech, Pharmacogenomics, Side Effects